Aldosterone antagonists for people with chronic kidney disease requiring dialysis

Review (16 RCTs; n=1446) found moderate certainty evidence that aldosterone antagonists probably reduces risk of all‐cause and CV death and probably reduces morbidity due to CV and cerebrovascular disease in this population, with increased risk of gynaecomastia, vs. control.

Source:

Cochrane Database of Systematic Reviews